Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 2
|
pubmed:dateCreated |
1990-5-25
|
pubmed:abstractText |
The diabetogenic agent streptozotocin (STZ) was injected intraperitoneally in Long-Evans and arginine vasopressin (AVP)-deficient Brattleboro rats. Twenty-eight days later both strains had a bradycardia and systolic hypotension; STZ-treated Brattleboro rats also had diastolic hypotension. The vasopressin (V1-receptor) antagonist, d(CH2)5[Tyr(Et)]DAVP, had no effect on resting blood pressure (BP) or heart rate (HR) in either strain of rat, indicating the relative maintenance of diastolic BP in STZ-treated Long-Evans rats was not dependent on acute vascular actions of AVP. Captopril caused a modest hypotension in all groups of rats, indicating that BP was not differentially dependent on the renin-angiotensin system in the different groups. In the presence of captopril and the ganglion blocker, pentolinium tartrate, the AVP-mediated recovery in BP was impaired in STZ-treated Long-Evans rats. During administration of d(CH2)5[Tyr(Et)]DAVP and pentolinium, the angiotensin II (ANG II)-mediated BP recovery was smaller in both groups of STZ-treated rats, indicating that this abnormality was not likely to be caused by inhibition of renin release by AVP. The abnormalities in ANG II- and AVP-mediated recovery were prevented by insulin treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Pentolinium Tartrate,
http://linkedlifedata.com/resource/pubmed/chemical/SK&F 100398,
http://linkedlifedata.com/resource/pubmed/chemical/Streptozocin,
http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
258
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R852-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2139547-Animals,
pubmed-meshheading:2139547-Arginine Vasopressin,
pubmed-meshheading:2139547-Blood Pressure,
pubmed-meshheading:2139547-Captopril,
pubmed-meshheading:2139547-Cardiovascular System,
pubmed-meshheading:2139547-Heart Rate,
pubmed-meshheading:2139547-Male,
pubmed-meshheading:2139547-Pentolinium Tartrate,
pubmed-meshheading:2139547-Rats,
pubmed-meshheading:2139547-Rats, Brattleboro,
pubmed-meshheading:2139547-Rats, Inbred Strains,
pubmed-meshheading:2139547-Rats, Mutant Strains,
pubmed-meshheading:2139547-Streptozocin,
pubmed-meshheading:2139547-Vasopressins
|
pubmed:year |
1990
|
pubmed:articleTitle |
Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats.
|
pubmed:affiliation |
Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|